QL1706 (Iparomlimab/Tuvonralimab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QL1706 (Iparomlimab/Tuvonralimab), covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma [Phase 2]